About the event
This international forum is being held under the Chatham House Rule. The purpose is to build on the momentum generated by Ebola and Zika to focus attention on the need for comprehensive reform of the vaccine development process and how to accelerate the availability of new vaccines in advance of epidemics.
Topics for discussion include advances in science and technology, global research priorities, resource needs, financial gaps, resource allocation, mobilization of new assets, the merits and feasibility of different financing mechanisms that have been proposed to bridge these gaps, and the exploration of opportunities for greater collaboration and partnerships globally to maximize synergies and achieve mutual goals.
The Foundation for Vaccine Research
The National Academy of Medicine
Event chairs and event co-chairs
Victor J Dzau
Adel A F Mahmoud
Salim Abdool Karim
Speakers (in order of presentation)
Event format and target audience
This event is designed for decision makers, policy makers and other leaders, bringing together 125 scientists, industry leaders, funders, public health officials and other experts from the United States and globally, with knowledge of the challenges facing vaccine developers.
A set of recommendations will emerge from the meeting that will advance the global discussion currently underway on how to accelerate the development and availability of new vaccines. The meeting should generate increased support for exploring new mechanisms to leverage financing and mobilize new assets to speed vaccine development.
Date and venue
Sunday 15 May evening: Please note that the opening session and welcome reception at the NAS building have been cancelled.
The private dinner for speakers and invited guests on Sunday evening will still take place (venue to be announced) but will start at 6:00 pm instead of 8:00 pm.
Monday 16 May: Main event - all-day meeting from 8:00 am to 6:00 pm in the Lecture Room at the National Academy of Sciences building at 2101 Constitution Avenue NW, in Washington, DC.
Mix of topics
50% science, 50% policy. The agenda will allow ample time for discussion at the end of each session, and a full hour for discussion in the last session of the day.
Event sponsors and strategic partners
The Bill & Melinda Gates Foundation
The Wellcome Trust
For more information, see www.vaccinefoundation.org